Last reviewed · How we verify
Anti-Smoking Drug (anti-smoking-drug)
Anti-Smoking Drug (generic name: anti-smoking-drug) is a drug developed by Pfizer Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | anti-smoking-drug |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
- Cervicalgia
- Flu-like symptoms
- Increased arthritis symptoms
- Itchiness/skin irritation at site of nicotine patch
- Nausea
- Increased anxiety
- Congestion
- Stomach pain/flank pain
Key clinical trials
- Digital Media for Cancer Control (to Prevent Vaping and Smoking Behavior) (NA)
- Liraglutide Effect in Atrial Fibrillation (PHASE4)
- Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility (NA)
- ISCHEMIA-EXTEND (Extended Follow-up)
- Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes (PHASE4)
- Metabolic Surgery for Atrial Fibrillation Elimination (PHASE4)
- Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer (EARLY_PHASE1)
- Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-Smoking Drug CI brief — competitive landscape report
- Anti-Smoking Drug updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Anti-Smoking Drug
What is Anti-Smoking Drug?
Anti-Smoking Drug (anti-smoking-drug) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Anti-Smoking Drug?
Anti-Smoking Drug is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Anti-Smoking Drug?
anti-smoking-drug is the generic (nonproprietary) name of Anti-Smoking Drug.
What development phase is Anti-Smoking Drug in?
Anti-Smoking Drug is in Phase 1.
What are the side effects of Anti-Smoking Drug?
Common side effects of Anti-Smoking Drug include Cervicalgia, Flu-like symptoms, Increased arthritis symptoms, Itchiness/skin irritation at site of nicotine patch, Nausea, Increased anxiety.
Related
- Manufacturer: Pfizer Inc. — full pipeline
- Compare: Anti-Smoking Drug vs similar drugs
- Pricing: Anti-Smoking Drug cost, discount & access